Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average recommendation of “Moderate Buy” from the eleven ratings firms that are covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year […]
Frontier Capital Management Co. LLC lessened its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,336 shares of the medical research company’s stock after selling 279 shares during the […]
Woodley Farra Manion Portfolio Management Inc. boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 107,058 shares of the medical research company’s stock after purchasing an additional 2,253 shares […]
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 0.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,633 shares of the medical research company’s stock after […]
Covestor Ltd grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 259.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 219 shares of the medical research company’s stock after purchasing an additional 158 shares during the […]